Cardior Pharmaceuticals
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $91M
Investors
- 10
About Cardior Pharmaceuticals
Based in Hannover, Germany, and founded in 2016 by co-founders Claudia Ulbrich MD, Thomas Thum MD, and Sandor Batkai, Cardior Pharmaceuticals GmbH operates as a provider of RNA-based therapies to halt and reverse cardiac remodeling post-myocardial infarction, targeting heart disease patients.025 billion, including an upfront payment. The company provides a wide range of therapeutic solutions, such as non-coding RNA-based therapies to reverse adverse cardiac remodeling and improve heart function. Additionally, the firm also provides clinical trial services to evaluate treatment efficacy and safety.
Who invested in Cardior Pharmaceuticals
10 investors across 2 rounds
See all investors in Cardior Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cardior Pharmaceuticals
Who invested in Cardior Pharmaceuticals?
Cardior Pharmaceuticals has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cardior Pharmaceuticals raised?
Cardior Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cardior Pharmaceuticals last raise money?
Cardior Pharmaceuticals's most recent round on record is a Series B, in Aug 2021.
What does Cardior Pharmaceuticals do?
Based in Hannover, Germany, and founded in 2016 by co-founders Claudia Ulbrich MD, Thomas Thum MD, and Sandor Batkai, Cardior Pharmaceuticals GmbH operates as a provider of RNA-based therapies to halt and reverse cardiac remodeling post-myocardial infarction, targeting heart disease patients.
Where is Cardior Pharmaceuticals headquartered?
Cardior Pharmaceuticals is headquartered in Hannover, Germany.
Which VCs invest in companies like Cardior Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Cardior Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cardior Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.